Why Is Neuromuscular-Focused Dyne Therapeutics Stock Trading Lower On Friday?
Dyne Therapeutics' DYNE-101 shows promising Phase 1/2 results for myotonic dystrophy type 1, with plans for Accelerated ...
ENDPOINTS NEWS23h
Dyne de­tails piv­otal plans for my­oton­ic dy­s­tro­phy RNA drug, though da­ta blip wor­ries some in­vestors
Dyne Therapeutics touted an early-stage study of its RNA treatment for myotonic dystrophy type 1 and has selected the dose it ...
Billboard15h
Adult Alternative Airplay
THE WEEK’S MOST POPULAR SONGS RANKED BY ADULT ALTERNATIVE RADIO AIRPLAY DETECTIONS, AS MEASURED BY MEDIABASE AND PROVIDED BY LUMINATE. STATIONS ARE ELECTRONICALLY MONITORED 24 HOURS A DAY ...